Propanc Biopharma PPCB
NASDAQ PPCB
$0.50 +0.00 (+0.16%)
As of: Oct 2, 2026 · 12:22 PM EDT

Propanc Biopharma (PPCB) Change in Intangibles (2011)

Updated

Propanc Biopharma (PPCB) reported Change in Intangibles of $619.00 for fiscal Q4 2011 (quarter ended Jun 30, 2011), down 72.2% from the prior quarter.

Analysis

Propanc Biopharma (PPCB) Change in Intangibles (2011) Analysis & Trends

For FY2011 (ended Jun 30, 2011), Propanc Biopharma posted Change in Intangibles of $25,726.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Intangibless (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -437.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -2.34 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Propanc Biopharma 550,617.42 550,617.42 - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2011 619.00
Mar 31, 2011 2,225.00
API Access

Propanc Biopharma Change in Intangibles API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-intangibles&ticker=PPCB&period=max&api_key=YOUR_API_KEY